INTRODUCTION
Under the stimulation with specifi c antigens, B cells are activated and functionally matured, thereby exerting immunological functions including antigen presentation and production of multiple cytokines (LeBien and Tedder, 2008; Mauri and Bosma, 2012) . Finally, B cells differentiate into antibody secreting cells (ASCs), which are involved in anti-infection immunity and the pathogenesis of immune-related diseases through production of antigen-specifi c antibodies (Slifka and Ahmed, 1998; Radbruch et al., 2006) . It is also evident that ASCs play important roles in negative immune regulation. For instance, CD138 + plasma cell-like B cells express IL-10 and exhibit regulatory capability in vivo (Neves et al., 2010) . Lack of B cells is a main reason responsible for the immunologic disorders in chronic colitis of TCR-α −/− mice (Mizoguchi et al., 1997) .
Although calreticulin (CRT) is a major endoplasmic reticulum (ER) residential Ca2
+ -binding and molecule chaperoning protein (Krause and Michalak, 1997; Vassilakos et al., 1998; Arosa et al., 1999; Michalak et al., 1999) , soluble CRT can be detected in the serum of patients with autoimmune diseases such as systemic lupus erythematosus (SLE) or rheumatoid arthritis (RA) (Hong et al., 2010; Tarr et al., 2010; Ni et al., 2013) . More importantly, recombinant CRT fragments (e.g. rCRT/39-272) possess potent immunostimulatory activities on macrophages (cytokine production) and B cells (Ig secretion and class switching) (Hong et al., 2010) . Self-oligomerization is essential for the potent immunological activities of soluble CRT (Jorgensen et al., 2003; Carpio et al., 2013; Huang et al., 2013) . Moreover, intraperitoneal (i.p.) administration of rCRT/39-272 modulates T cell-mediated inflammatory responses in mice with experimental autoimmune encephalomyelitis (EAE) via activation/expansion of regulatory CD1d hi CD5 + IL-10-secreting B cells (B10 cells) . Under the stimulation with TLR agonists, B10 cells produce IL-10 which subsequently regulates the balance of Th1/Th2 differentiation both in vitro and in vivo . Recently, Maseda et al. reported that regulatory B10 cells could differentiate into ASCs after a transient IL-10-producing stage, and the resultant ASCs contribute to the production of serum polyreactive antibodies (Maseda et al., 2012) . Likewise, Madan et al.
&
cantly in the rCRT/39-272 group, which is consistent with our previous report that rCRT/39-272 drives IL-10 production by B cells in vitro . In line with the essential role of self-oligomerization in rCRT's stimulating effect on macrophages and B cells (Huang et al., 2013) , rCRT oligomers exhibited stronger ability in driving B cell differentiation into ASCs than did rCRT monomers (Fig. 1C) .
rCRT/39-272 augments the differentiation of ASCs from B1 cells in vivo
To evaluate the effect of rCRT/39-272 on ASC differentiation in vivo, naïve C57BL/6 mice were i.p. injected with rCRT/39-272 or rEGFP, and sacrificed 3 days later for splenocytes. As shown in Fig. 2A also demonstrated that LPS-induced IL-10-secreting B cells exhibited phenotypic characteristics of plasma cells (Jeong et al., 2012) . Therefore, the present study was designed to address the question whether rCRT/39-272-activated CD1d hi CD5 + cells could make further differentiation into ASCs both in vitro and in vivo. (DiLillo et al., 2008) in the rCRT/39-272 group increased from less than 1% to 4.3%, significantly higher than that of the rEGFP group (Fig. 1A) . Plasma cell differentiation is known to be associated with the expression of several transcription factors (e.g. blimp1, xbp1, and irf4) and suppression of pax5 and bcl6 (Calame et al., 2003) . As illustrated in Fig. 1B , expression levels of xbp1, irf4, and blimp1 in the rCRT/39-272-treated B cells were approximately 4.5, 1.6, and 5.6 folds higher, respectively, than that of the rEGFP-treated counterparts, whilst the pax5 and bcl6 transcripts were markedly reduced in the rCRT/39-272-treated B cells. The il10 transcript in B cells was also increased signifi - (Fig. 3A) . Interestingly, these Abs were able to bind dsDNA and ssDNA, but not histone, rCRT/39-272 or rEGFP, with relatively high affi nity in ELISAs ( Fig. 3B-F 
RESULTS
OD (492 nm (Fig. 4C ). It should be noted that the frequency of CRT-specifi c IgG-secreting ASCs in the rCRT/39-272 group was surprisingly low (Fig. 4D) , which seems inconsistent with the higher titer CRT-specific IgG Abs in mice after rCRT/39-272 immunization, shown in Fig. 4A , but can be explained by more superior binding affi nity and specifi city of the IgG Abs.
rCRT/39-272 induces ASC differentiation in EAE mice
Our previous work showed that i.p. administered rCRT/39-272 inhibits murine EAE severity via activation/expansion of B10 cells in vivo, most of which were derived from B1 cells . It was of interest to determine whether rCRT/39-272 could also drive ASC differentiation in mice with EAE. Naïve C57BL/6 mice were immunized with MOG 35-55 peptide for EAE induction, followed by i.p. injections of 100 μg rCRT/39-272 responses in DTH and EAE models by interfering its activation and differentiation (Qiu et al., 2012 (Hong et al., 2010) , rCRT/39-272, but not rEGFP, induced strong antigen-specifi c IgM and IgG responses in vivo (Fig. 4A) , refl ecting the substantial expansion and ASC differentiation of CRT-specifi c B cell clones after rCRT/39-272 administration. Fig. 4B shows that, 10 days after the fi nal immunization, percentage of the CD138 Serum samples were collected from the EAE mice, 9 days after induction, for quantitative analysis of IgM and IgG using ELISAs (E and F). Specifi city of the serum Abs was confi rmed by ELISAs based on rCRT/39-272 and MOG 35-55 (G) . This is a representative of three independent experiments.
Protein Cell
& tion was a phenomenon specifi c to prokaryotically expressed rCRT polypeptides, native CRT (nCRT), purifi ed from mouse livers ( Fig. 6A-D) , was tested for the ability to induce ASC differentiation. As illustrated in Fig. 6E-G 
DISCUSSION
We have previously shown that i.p. administration of rCRT/39-rCRT/39-272 treatment did not result in a further increase. However, the absolute number of CD1d hi CD5 + cells increased significantly in rCRT/39-272-treated EAE mice than that in control mice (Fig. 5D) . Concentration of serum antibodies in rCRT/39-272 treated EAE mice was signifi cantly higher than those in parallel groups ( Fig. 5E and 5F ). Thus, in accordance with the potent immunogenicity and immuno-adjuvanticity of rCRT/39-272, rCRT/39-272 treatment induced the production of both peptide specifi c antibodies in EAE mice (Fig. 5G) . To analyze the function of nCRT on ASC differentiation in EAE mice, C57BL/6 mice (n ≥ 3 mice in each group) were s.c. immunized with 100 μg MOG 35-55 peptide emulsifi ed in CFA to induce EAE. On the same day and 2 days later, 100 μg of nCRT or BSA in 200 μL PBS or PBS alone was given to these mice through i.p.. On day 9, mice were sacrifi ced and splenocytes were stained with fl uorescence-conjugated antibodies followed by fl ow cytometric analysis. 
Proteins
The recombinant murine CRT fragment 39-272 and recombinant EGFP were expressed in Escherichia coli (E. coli) BL21 and purifi ed using Ni-nitrilotriacetic acid resin (Novagen, Germany) according to the method previously described (Hong et al., 2010) . Both recombinant proteins were dialyzed to PBS (pH 7.4), followed by incubation and passing through polymyxin B agarose to deplete possible contaminated LPS. nCRT was purified from livers of mice using ammonium sulfate precipitation and DEAE ion-exchange column chromatography. In brief, mouse liver cells were lysed with lysis buffer (PBS containing 1% TRITON-X 100 and 1 mmol/L PMSF) after a cycle of freezing at -80°C and thawing, and centrifuge at 18,000 rpm for 15 min to obtain the lysis supernatant. Solid ammonium sulfate was added to the supernatant to reach 50% saturation, followed by another centrifuge at 18,000 rpm for 60 min. The precipitate was discarded and the supernatant was subjected to subsequent fractionation at 85% saturation of ammonium sulfate. After centrifugation at 18,000 rpm for 60 min, the precipitate was dissolved in Tris-HCl buffer (pH 7.4) containing 0.15 mol/L NaCl. The resultant solution was applied to a DEAE ion-exchange column (SephadexA-50, GE Healthcare, Sweden) and eluted with a linear gradient of 0.15-0.5 mol/L NaCl in 20 mmol/L Tris-HCl buffer (pH 7.4). All proteins used in this experiment were at over 90% purity as judged by Commassie brilliant blue-stained SDS-PAGE gels. All protein samples were sterile by passing through 0.22 μm fi ltration membrane, aliquoted and stored at -80°C until use.
rCRT oligomers and monomers were isolated from rCRT samples according to the method described previously (Huang et al., 2013) . Briefly, 5 mL of rCRT samples at a concentration of 10 mg/mL was loaded into a Sephadex G-75 (GE Healthcare, US) column (80 × 2 cm), followed by elution with 0.9% NaCl at 20 mL/h and collected every 2 mL volume. The purity of isolated fractions was judged by running samples onto Native-PAGE gels and stained with Commassie brilliant blue.
EAE induction and recombinant protein injection
Active EAE was induced in 6-10 weeks female C57BL/6 mice according to the method described previously . Briefl y, mice were s.c. immunized with 100 μg myelin oligodendrocyte glycoprotein ) peptide (MEVGWYRSPFSRVVHLYRNGK; GL Biochem Ltd., Shanghai, China) emulsified in CFA containing 4 mg/mL heat-killed Mycobacterium tuberculosis H37RA (Difco, USA) on day 0. Additionally, mice were received 200 ng pertussis toxin (Sigma, USA) i.p. in 500 μL PBS on day 0 and day 2. To investigate the effect of CRT on ASC differentiation in EAE mice, mice were given 100 μg of rCRT/39-272, nCRT, rEGFP, or BSA in 200 μL PBS through i.p. on day 0 and day 2. 9 days after the EAE induction, mice were sacrifi ced, ASC frequencies in spleen were analyzed by fl ow cytometry.
Flow cytometry analysis
Cells were collected and washed with PBS containing 1% BSA (Sigma-Aldrich), and FcRs were blocked using anti-mouse CD16/32 272 reduced mouse EAE severity by skewing the balance of Th1/Th2 differentiation, which is attributable to the activation/ expansion of regulatory IL-10-secreting CD1d + B cells in vitro (Fig. 6) , our results indicate a novel pathway responsible for the immunoregulation mediated by soluble CRT. This may be of importance as elevation of serum CRT levels is strongly correlated with autoimmune disorders such as RA and SLE in humans (Hong et al., 2010; Tarr et al., 2010) . Our recent study revealed that self-oligomerization is a key factor for the extraordinarily potent ability of rCRT to activate macrophages and B cells (Huang et al., 2013) . Another line of work in this laboratory has found that, incubation at 42°C or pH5 promotes nCRT oligomerization in vitro (He et al., unpublished data) , it is thus reasonable to suggest that soluble CRT released at the site of infl ammatory responses may self-oligomerize, thereby acquiring potent ability of inducing ASC differentiation. Molecular and cellular mechanisms underlying this phenomenon need further investigation. The immunoregulatory functions of ASCs have been demonstrated in various mouse models. For instance, B cells (as well as certain autoantibodies that they produce) can play roles as important negative regulators in intestinal infl ammation and suppress colitis (Mizoguchi et al., 1997; Genestier et al., 2007) . Antibodies specific for certain cell surface molecules can negatively regulate T cell responses by interfering T cell activation and differentiation (Zhang et al., 2003; Qiu et al., 2012) . Recently, Neves and coworkers (Neves et al., 2010) have reported that CD138 + plasma cell-like B cells could express IL-10 and suppress immunity to Salmonella infection through an IL-10-dependent pathway. In our study, treatment of CD1d hi CD5 + B cells with rCRT/39-272 in vitro led to not only their differentiation into ASCs but also production of DNA-specifi c autoantibodies (Fig. 3) . These data are in agreement with recent work by Maseda et al. showing that regulatory B cells produce germline-encoded nonpathogenic low affinity IgM (Maseda et al. 2012) . Since rCRT/39-272 is able to activate/ expand regulatory B10 cells that suppress immune responses in an IL-10 dependent manner , our results may suggest a differentiation pathway from CD1d 
MATERIALS AND METHODS

Mice
Female C57BL/6 mice between 6 to 10 weeks were purchased from the Model Animal Research Center (Nanjing, China). All animal experiments were performed according to the guideline for the Care and Use antibodies (BioLegend) for 20 min at room temperature. Subsequently, cells were incubated with FITC-conjugated rat anti-mouse B220 (BioLegend) and PE-conjugated CD138 or isotype controls (BD Bioscience) at 4°C for 30 min. In some experiments, Alexa Fluro 647-conjugated CD1d (BioLegend), PE cy7-conjugated CD5 (eBioscience) or fl uorescence-conjugated isotype controls were also included to mark specific B cell subsets. After the staining procedure and thorough washes, 7-AAD was added to exclude apoptotic cells before fl ow cytometric analysis using fl uorescence-activated cell sorter (FACS cantoII; Becton-Dickinson, Rutherford, NJ, USA).
Cell culture and isolation
For purifi cation of murine spleen CD19 positive B cells, mouse spleens were gently disaggregated by pressing with the fl at surface of a syringe plunger against a stainless steel sieve ( 200 mesh). RBCs were lysed by brief treatment with ACK lysis buffer. B cells were enriched by positive selection using CD19-microbeads (Miltenyi Biotec, Germany). The purity of purifi ed B cell population was typically over 95% judged by surface CD19 expression. 
CD5
+ B cell subsets were sorted using FACS Aria III fl ow cytometer (BD Bioscience) with purities over 70% and 90%, respectively. B cells were cultured in complete R10 medium: RPMI-1640 supplemented with 10% (v/v) fetal bovine serum (Hyclone, USA), penicillin/streptomycin (100 U/mL), L-glutamine (2 mmol/L) and 2-ME (5 × 10 -5 mol/L), in a 5% CO 2 incubator at 37°C, in the presence or absence of LPS (1 μg/mL, Sigma-Aldrich), rCRT/39-272 (30 μg/mL), nCRT (30 μg/mL), rEGFP (30 μg/mL) or BSA (30 μg/mL) (Sigma-Aldrich, cell culture grade) for 72 h before analysis. /well) were stimulated with 30 μg/mL rCRT/39-272, rEGFP in the presence or absence of rmIL-4 for 3 or 6 days. Concentrations of total IgM (3-day) and IgG1 (6-day) in the supernatant were determined using mouse IgM and IgG1 ELISA Quantitation Set (Bethyl Laboratories, Montgomery, TX) according to the manufacturer's instructions. Standard curves were established using mouse IgM and IgG1 and the assay detection limits were 15.6 and 7.8 ng/mL, respectively.
Antibody production and specifi city analysis
To analyze the antibody specifi city, ELISA plates (Nunc, Roskilde, Demark) were coated with rCRT/39-272, rEGFP, Histone (2 μg/mL; Roche, Germany), ssDNA, dsDNA (50 μg/mL; Sigma-Aldrich) in carbonate buffer (pH 9.6) at 4°C overnight. Before dried and coated with dsDNA and ssDNA, the plates were pretreated with protemine (100 μg/mL, Sigma-Aldrich) in water for 1 h at room temperature and then washed 5 times with water. The plate was subsequently incubated with blocking solution (2% BSA in PBS) for 2 h at 37°C. After washes, 100 μL of diluted culture supernatant was added in triplicates followed by incubation for 2 h at 37°C. After further washes with PBS-T, plates were incubated with HRP-labeled goat anti-mouse IgM or IgG1 antibodies (Southern Biotech, USA) for 1 h at 37°C. O-phenylenediamine (OPD) (Sigma) substrate was added (100 μL/well) and the plates were incubated for 2 min at room temperature, followed by the addition of 50 μL 2 mol/L H 2 SO 4 per well to terminate the reaction. Optical density (OD) was immediately read at 492 nm using an ELISA plate reader (Bio-Rad Laboratories Inc., Hercules, California, USA).
Real-time PCR
RNA extracted from enriched spleen B cells was used to generate cDNA, with relative transcript levels determined by reverse transcriptase quantitative real-time PCR of triplicate samples. Primers were described as below: for gapdh, forward primer 5′-CAAGGT-CATCCATGACAACTTTG-3′ and reverse primer 5′-GTCCACCACC-CTGTTGCTGTAG-3′; for il10, forward primer 5′-GGTTGCCAAGCCT-TATCGGA-3′ and reverse primer 5′-ACCTGCTCCACTGCCTTGCT-3′; for xbp1, forward primer 5′-AAACAGAGTAGCAGCGCAGACTGC-3′ and reverse primer 5′-TCCTTCTGGGTAGACCTCTGGGAG-3′; for bcl6, forward primer 5′-CACACTCGAATTCACTCTG-3′ and reverse primer 5′-TATTGCACCTTGGTGTTGG-3′; for blimp1, forward primer 5′-GGAGGATCTGACCCGAAT-3′ and reverse primer 5′-TC-CTCAAGACGGTCTGCA-3′; for irf4, forward primer 5′-CTCTTCAA-GGCTTGGGCATT-3′ and reverse primer 5′-TGCTCCTTTTTTGGCTC-CCT-3′; and for pax5, forward primer 5′-CAACAAACGCAAGAGGG-3′ and reverse primer 5′-GGGCTCGTCAAGTTGG-3′. Cycle conditions were described as follows: one denaturation step of 94°C for 2 min, followed by 40 cycles of 94°C for 30 s, 60°C for 30 s, and 72°C for 1 min. PCR products were controlled for purity by analysis of their melting curves. Expression threshold values (ΔCt) for each transcript were determined by normalizing to gapdh expression within each sample group.
ELISPOT assay
The frequencies of Ab-secreting cells among purifi ed CD1d were added to Immobilon-P Multi-screen 96-well plates (Millipore) that were precoated with rCRT/39-272 (2 μg/mL) at either 10 5 (IgM) or 2 × 10 5 (IgG) cells/well in complete R10 medium (100 μL). After incubating the plates for 5 h (for IgM) or 24 h (for IgG) at 37°C in a humidifi ed CO 2 incubator, the plates were washed three times and incubated with HRP-conjugated polyclonal goat anti-mouse IgM or IgG Abs (Southern Biotechnology Associates) for 1 h at room temperature. After washing, the plates were colored using TMB substrate (Sigma-Aldrich).
Statistical analysis
All experiments described above were repeated at least three times.
Comparison of the data was performed using the Student's t-test. Signifi cance was defi ned as P < 0.05.
